These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3573463)

  • 21. [Intravesical chemotherapy for superficial bladder tumors].
    Ohmori H
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1557-62. PubMed ID: 6206797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in chemotherapy for renal cell carcinoma.
    Huben RP
    Semin Urol; 1992 Feb; 10(1):16-22. PubMed ID: 1565899
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of UFT for the treatment of renal cell carcinoma.
    Masuda F; Mori Y; Nakada J
    Prog Clin Biol Res; 1989; 303():707-9. PubMed ID: 2506559
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined interferon and vinblastine treatment in advanced renal cell cancer.
    Kellokumpu-Lehtinen P; Jantunen I; Flander M; Johansson R; Nordman E
    Acta Oncol; 1995; 34(7):975-7. PubMed ID: 7492395
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase II trial of methyl-gag and melphalan in metastatic adult renal cell carcinoma.
    Guimaraes JL; Ghosn M; Ostronoff M; Azab M; Theodore C; Droz JP
    Cancer Invest; 1990; 8(6):623-4. PubMed ID: 2292054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study of UFT in far-advanced renal cell carcinoma].
    Matsuyama H; Yamamoto N; Sakatoku J; Hara Y; Sacho T; Yasui H; Ichikawa T; Koshido Y; Hayasida S; Nagata K
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):527-30. PubMed ID: 3126711
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
    Yagoda A; Abi-Rached B; Petrylak D
    Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapy for renal cell carcinoma.
    Amato RJ
    Semin Oncol; 2000 Apr; 27(2):177-86. PubMed ID: 10768596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal cell carcinoma: trying but failing to improve the only curative therapy.
    Acquavella N; Fojo T
    J Immunother; 2013; 36(9):459-61. PubMed ID: 24145356
    [No Abstract]   [Full Text] [Related]  

  • 30. Twelve-year experience with chemotherapy in adult metastatic renal cell carcinoma at the Institut Gustave-Roussy.
    Droz JP; Theodore C; Ghosn M; Lupera H; Piot G; De Forges A; Klink M; Rouesse J; Amiel JL
    Semin Surg Oncol; 1988; 4(2):97-9. PubMed ID: 3393780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II evaluation of 4'deoxydoxorubicin in advanced renal cell carcinoma.
    Kish JA; Ensley JF; al-Sarraf M
    Am J Clin Oncol; 1990 Feb; 13(1):17-8. PubMed ID: 2305717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxic chemotherapy for advanced renal cell carcinoma.
    Yagoda A; Petrylak D; Thompson S
    Urol Clin North Am; 1993 May; 20(2):303-21. PubMed ID: 8493752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromophobe renal cell carcinoma with prolonged response to sequential sunitinib and everolimus.
    Larkin JM; Fisher RA; Pickering LM; Sohaib SA; Ghosn M; Christmas T; Cordiner RL; Gore ME
    J Clin Oncol; 2011 Mar; 29(9):e241-2. PubMed ID: 21245426
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of intravesical chemotherapy on superficial urinary bladder cancer].
    Moriyama M; Kubota Y; Miura T; Shuin T; Noguchi S
    Hinyokika Kiyo; 1983 Mar; 29(3):351-5. PubMed ID: 6203382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB).
    Sorio R; Galligioni E; Crivellari D; Talamini R; Monfardini S
    Ann Oncol; 1995 Mar; 6(3):306-7. PubMed ID: 7612500
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current status of chemotherapy for renal cell carcinoma].
    Kato T; Sato K
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):23-8. PubMed ID: 8291912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged survival in renal transplant recipient with advanced renal cell carcinoma by everolimus and sorafenib.
    Ruangkanchanasetr P; Kanjanapayak B; Jungmeechoke K
    Nephrology (Carlton); 2011 Jan; 16(1):118-9. PubMed ID: 21175989
    [No Abstract]   [Full Text] [Related]  

  • 38. Combination therapy with adriamycin and interleukin 2 augments immunity against murine renal cell carcinoma.
    Gautam SC; Chikkala NF; Ganapathi R; Hamilton TA
    Cancer Res; 1991 Nov; 51(22):6133-7. PubMed ID: 1682042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboquone combined with methotrexate and 5-fluorouracil for recurrent and advanced ovarian cancer.
    Mäenpää JU; Heinonen E; Karnani P; Kauppila A; Kuoppala T; Salmi T; Sipilä P; Nieminen U
    Eur J Cancer; 1993; 29A(11):1633. PubMed ID: 8217372
    [No Abstract]   [Full Text] [Related]  

  • 40. Coumarin plus cimetidine: yet another angle for therapy of renal cell carcinoma.
    Kirkwood JM; Ernstoff MS
    J Clin Oncol; 1987 Jun; 5(6):836-7. PubMed ID: 3585440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.